Connect with us

National

National news in brief

Civil unions bill in Colo., amendment push in N.C. and more

Published

on

Colo. senator introduces civil unions bill

DENVER — A Colorado state senator introduced a civil unions bill on Feb. 14. “Civil unions will allow committed couples to share in the responsibilities and protections in Colorado law that most families take for granted,” Sen. Pat Steadman said in a press release. He said he considered the less-than-equal argument many gays make against civil unions but said everyday matters like medical care and inheritance are too vital to ignore, according to reports from the Colorado Independent. Coloradans voted in 2006 to ban same-sex marriage but polls show deep support in the state for civil unions.

San Francisco mural draws controversy

SAN FRANCISCO — A proposed mural on San Francisco’s Polk Street in the city’s Tenderloin neighborhood has drawn controversy, a California NBC affiliate reported. Artists who unveiled a sketch of the mural were met with backlash at a community meeting last month. Attendees didn’t like the quality of the art and content that alluded to the neighborhood’s gay history. The artists said the Lower Polk Neighborhood Association hired them to paint a gay history mural. Before the ’70s, when the Castro emerged as the city’s gay area, Polk Street was the center of gay life. Some who objected say the era is too rife with well-documented incidents of police harassment and brutality to warrant a nostalgic mural.

Anti-gay marriage amendment filed in N.C.

RALEIGH, N.C. — A North Carolina state senator this week filed a constitutional amendment to ban same-sex marriage. The text of the proposed amendment, which has not yet been filed in the House, would ban any recognition of any “domestic legal union” other than a marriage between an opposite-sex couple, Q Notes, a Charlotte-based LGBT newspaper reported. If approved by the legislature, the amendment would appear on the November 2012 ballot. Three-fifths of both the House and Senate must approve the amendment before it can appear on the ballot; the governor has no veto authority on amendments. Republican state Sen. James Forrester of Gaston County filed the amendment. The state has laws against same-sex marriage but not a constitutional amendment.

Alaska regents vote to ban anti-gay bias

ANCHORAGE, Alaska — The University of Alaska Board of Regents voted last week to ban discrimination based on sexual orientation, with its president saying the state may have been the only one in the nation not to have sexual orientation specifically listed as a protection in a public university policy, the Associated Press reported this week. The proposal, approved 8-2, adds sexual orientation to university policy that bans discrimination.

Gays barred from Creation Museum ‘date night’

PETERSBURG, Ky. — A “date night” event at the Kentucky-based Creation Museum was disrupted earlier this month when a male couple was denied admission, the Associated Press reported. A friend of one of the men who was barred entry, told the AP no one in their group was gay but Joe Sonka, the man who was not allowed in, had blogged in January that a “flamboyantly” gay couple should attend the tour and told security guards he was waiting for his “date” who was male. Mark Looy, chief communications officer for the Creation Museum, said it was clear from promotional material that the event was for straight couples only and said it presented the “biblical view of marriage.”

Facebook adds two relationship status options

SAN FRANCISCO — Facebook recently began offering users new ways to describe their romantic situation by adding “in a civil union” and “in a domestic partnership” to its official list of relationship statuses, according to reports from many news outlets this week. In the past, Facebook’s 600 million users were offered choices including “single,” “in a relationship” and “it’s complicated.” The decision to include the options came after Facebook negotiated with users and rights advocacy groups, a company rep told the San Francisco Chronicle. Facebook co-founder Chris Hughes is openly gay. The option is available in the U.S., Canada, the U.K. and France.

Kansas student op-ed draws controversy

WICHITA, Kan. — Gay rights advocates in Kansas are calling for Wichita school leaders to “undo the damage and hurt” caused by a student newspaper column that they say promotes violence against gays, according to a report from the Wichita Eagle, a regional paper. The opinion column, published Feb. 11 in the editorial section of the Messenger, East High School’s student newspaper, says same-sex relationships “just are not normal” and “should be frowned upon.” Its author, an East High student, also cited a Bible verse that says men who lie with other men have “committed an abomination: they shall surely be put to death.” District officials, the newspaper’s faculty adviser and student editors say the column constitutes free speech and is protected by the First Amendment and the Kansas Student Publications Act. Jessica Thomas, a senior at East High and one of the newspaper’s three editors, said she and her colleagues “knew the column could possibly be controversial.” “We don’t necessarily agree or disagree. It’s one person’s personal opinion,” she said. Kansas law “very tightly restricts” teachers’ or school administrators’ ability to interfere with what students want to publish, Frank LoMonte, executive director of the Student Press Law Center in Washington, told the Eagle. The Kansas Student Publications Act says “material shall not be suppressed solely because it involves political or controversial subject matter.” A journalism teacher said it met the criteria for free speech. But Michael Jones, an editor for the national website Change.org, wrote in a blog post last week that the East High column “suggested it would be moral to execute an entire population of students.”

Advertisement
FUND LGBTQ JOURNALISM
SIGN UP FOR E-BLAST

Israel

A Wider Bridge to close

LGBTQ Jewish group said financial challenges prompted decision

Published

on

U.S. Rep. Debbie Wasserman Schultz (D-Fla.) speaks at the Capital Jewish Museum in D.C. on June 5, 2025, after A Wider Bridge honored her at its Pride event. A Wider Bridge has announced it will shut down. (Washington Blade photo by Michael K. Lavers)

A Wider Bridge on Friday announced it will shut down at the end of the month.

The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.

“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.

“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”

Arthur Slepian founded A Wider Bridge in 2010.

The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.

A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.  

The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.

A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.

“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”

Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.

Continue Reading

The White House

‘Trump Rx’ plan includes sharp cuts to HIV drug prices

President made announcement on Friday

Published

on

President Donald Trump during his meeting on lowering drug prices through TrumpRx. (Washington Blade photo by Joe Reberkenny)

President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.

During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.

“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”

Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”

“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.

Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.

Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.

Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.

Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.

These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”

Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.

“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”

Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.

“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.

“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.

Trump interjected, asking, “And that’s working well with HIV?”

“Yes,” O’Day replied.

“It’s a big event,” Trump said.

“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.

A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.

Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.

According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.

The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.

Continue Reading

The White House

EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine

Trans former assistant health secretary’s name changed on official portrait

Published

on

Adm. Rachel Levine (Washington Blade photo by Michael Key)

Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.

The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.

Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.

According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.

Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.

“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.

“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”

“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”

The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.

The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.

The Washington Blade reached out to HHS, but has not received any comment.

The lawsuit and four FOIA requests are below:

Continue Reading

Popular